Agilent Technologies, INC

Agilent Technologies has completed a $600 million private placement of 4.900% senior unsecured notes maturing in 2032.

Agilent Technologies announced the appointment of Michael Buckner as its new Chief Legal Officer, effective May 4, 2026, succeeding Bret DiMarco.

Agilent Technologies files an amendment to a previous 8-K report to correct a filing header error, clarifying the disclosure pertains to executive transition arrangements.

Agilent Technologies stockholders approved a phased declassification of its Board of Directors and adopted new bylaws, enhancing corporate governance.

Agilent Technologies, Inc. announced that Rodney Gonsalves, Vice President, Corporate Controller, and Principal Accounting Officer, will retire in January 2027.

Agilent Technologies delivered solid first-quarter fiscal year 2026 financial results, reporting $1.80 billion in revenue and raising its full-year reported revenue and non-GAAP EPS guidance.

Agilent Technologies announced a 10% increase in net revenue for the second quarter of fiscal year 2026, driven by broad-based growth across all segments and geographic regions.

Agilent Technologies reports a 7% increase in Q1 net revenue to $1.798 billion, driven by growth across all segments and regions, despite a 4% decline in net income to $305 million.

Agilent Technologies reports strong third-quarter revenue growth of 10% and a 19% increase in net income, driven by its Life Sciences and Diagnostics Markets segment, despite ongoing restructuring costs and tariff impacts.

Agilent Technologies reported a 6% increase in net revenue for the three months ended April 30, 2025, reaching $1.668 billion, but saw a significant 30% decline in net income to $215 million, impacted by higher operating costs and restructuring expenses.

Agilent Technologies' first quarter 2025 results show a slight increase in revenue but a decrease in net income compared to the same period last year, driven by currency headwinds and changes in segment performance.

Agilent Technologies' Q3 2024 results show a decrease in revenue and an increase in net income, alongside ongoing restructuring efforts and a new acquisition.

Agilent Technologies achieved 7% net revenue growth in fiscal year 2025, reaching $6.95 billion, driven by strong performance in Life Sciences and Diagnostics Markets, alongside strategic restructuring and share repurchases.

Agilent Technologies' fiscal year 2024 saw a 5% revenue decrease, primarily due to reduced customer spending in the pharmaceutical sector, though the Agilent CrossLab business showed growth.

Agilent Technologies' President and CEO, Padraig McDonnell, disposed of 418 shares of common stock to cover tax liabilities from restricted stock unit vesting.

Agilent Technologies Director Mikael Dolsten reported a transaction involving the acquisition of 1,600 shares of common stock.

Michael Steven Buckner, Senior Vice President at Agilent Technologies, reported a transaction involving 8,872 shares of common stock.

Agilent Technologies Senior Vice President Simon May reported a transaction involving the sale of 368 shares of common stock on May 8, 2026, to cover tax liabilities.

Agilent Technologies Director Sue H. Rataj acquired 2,158 shares of common stock valued at $241,195.50 as part of a compensation award.

Agilent Technologies Director Otis W. Brawley reported a pre-planned acquisition of 3,131.693 shares of common stock on March 19, 2026, through compensation plans and dividend reinvestment, with receipt deferred.

Agilent Technologies' latest proxy statement details proposals for its 2026 annual meeting, including director elections, executive compensation, auditor ratification, and a significant board declassification initiative.

Agilent Technologies has updated its proxy statement to reflect an additional public company directorship held by director nominee Mikael Dolsten, M.D., Ph.D.

Agilent Technologies will hold its annual stockholders meeting on March 13, 2025, to vote on director elections, executive compensation, auditor ratification, and corporate governance matters.

Agilent Technologies has announced its 2025 annual meeting, featuring director elections, executive compensation advisory vote, and a proposal to eliminate supermajority voting requirements.

Vanguard Capital Management has reported a beneficial ownership of 7.49% in Agilent Technologies Inc., holding over 21 million shares.

Vanguard Portfolio Management reports beneficial ownership of over 14.3 million shares, representing 5.09% of Agilent Technologies Inc.'s common stock as of March 31, 2026.

The Vanguard Group filed an amended Schedule 13G, reporting zero beneficial ownership in Agilent Technologies Inc. following an internal realignment.

BlackRock, Inc. has filed an amended Schedule 13G, reporting beneficial ownership of 8.3% of Agilent Technologies Inc.'s common stock as of March 31, 2025.

Massachusetts Financial Services Company (MFS) has disclosed a reduction in its beneficial ownership of Agilent Technologies, Inc. common stock to 4.4%, down from a previously held position above 5%.